BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $824,000 | -21.0% | 15,300 | -5.8% | 0.01% | -16.7% |
| Q2 2022 | $1,043,000 | +147.2% | 16,240 | +198.6% | 0.01% | +200.0% |
| Q1 2022 | $422,000 | +0.5% | 5,439 | +11.2% | 0.00% | 0.0% |
| Q4 2021 | $420,000 | -83.5% | 4,890 | -83.5% | 0.00% | -89.5% |
| Q2 2020 | $2,548,000 | -29.4% | 29,592 | -33.4% | 0.02% | -36.7% |
| Q1 2020 | $3,607,000 | -35.5% | 44,426 | -33.6% | 0.03% | -18.9% |
| Q4 2019 | $5,596,000 | -0.1% | 66,926 | +4.5% | 0.04% | -5.1% |
| Q3 2019 | $5,599,000 | +568.9% | 64,015 | +521.5% | 0.04% | +550.0% |
| Q1 2019 | $837,000 | -94.1% | 10,300 | -95.2% | 0.01% | -94.7% |
| Q4 2018 | $14,258,000 | -51.5% | 216,617 | -43.2% | 0.11% | -42.7% |
| Q3 2018 | $29,380,000 | +4.9% | 381,117 | +0.4% | 0.20% | 0.0% |
| Q2 2018 | $28,016,000 | +19.9% | 379,417 | +5.6% | 0.20% | +39.2% |
| Q1 2018 | $23,375,000 | +1.9% | 359,400 | +1.3% | 0.14% | +5.9% |
| Q4 2017 | $22,941,000 | +4.2% | 354,900 | +1.1% | 0.14% | +4.7% |
| Q3 2017 | $22,019,000 | +253.1% | 350,900 | +240.7% | 0.13% | +279.4% |
| Q2 2017 | $6,236,000 | +61.6% | 103,000 | +38.4% | 0.03% | +54.5% |
| Q1 2017 | $3,858,000 | +134.0% | 74,400 | +104.0% | 0.02% | +214.3% |
| Q2 2016 | $1,649,000 | +23.2% | 36,465 | +11.9% | 0.01% | +40.0% |
| Q1 2016 | $1,339,000 | -32.8% | 32,592 | -37.6% | 0.01% | -28.6% |
| Q4 2015 | $1,993,000 | +10.2% | 52,246 | -5.1% | 0.01% | +16.7% |
| Q3 2015 | $1,808,000 | -86.0% | 55,046 | -70.3% | 0.01% | -85.7% |
| Q2 2015 | $12,951,000 | -55.3% | 185,204 | -56.2% | 0.04% | -51.7% |
| Q1 2015 | $28,994,000 | -82.3% | 423,273 | -81.1% | 0.09% | -80.3% |
| Q4 2014 | $164,213,000 | -29.7% | 2,240,590 | -31.1% | 0.44% | -28.5% |
| Q3 2014 | $233,479,000 | -5.0% | 3,253,150 | -4.3% | 0.62% | -7.3% |
| Q2 2014 | $245,657,000 | -5.2% | 3,397,750 | -3.5% | 0.67% | -1.3% |
| Q1 2014 | $259,101,000 | +27.6% | 3,521,356 | +20.6% | 0.68% | +37.1% |
| Q4 2013 | $203,080,000 | +14.1% | 2,919,918 | +7.8% | 0.49% | +5.1% |
| Q3 2013 | $177,971,000 | +20.5% | 2,709,258 | +27.1% | 0.47% | +21.8% |
| Q2 2013 | $147,699,000 | – | 2,132,223 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |